Eli Lilly’s Zepbound is still viewed as the leading weight-loss shot, according to a market analyst who compared the drug to a rival injection from Pfizer. The comment comes as drugmakers race to meet ...

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

Stream NBC 5 for free, 24/7, wherever you are. The results were presented at a medical conference late last year, and did not compare Pfizer's drug with Ozempic or other weight loss medications. JAMA ...

Pfizer hasn't yet tapped into the highly lucrative market of diabetes drugs that have been increasingly used for weight loss purposes. Searching for a weight-loss drug but don't like the idea of an ...

Weight loss with Ozempic or Wegovy requires patients to inject themselves with the medication — a reported drawback for some people. That's why Pfizer and other drug manufacturers are racing for ...